JPH05229930A - Skin-whitening cosmetic - Google Patents

Skin-whitening cosmetic

Info

Publication number
JPH05229930A
JPH05229930A JP4070197A JP7019792A JPH05229930A JP H05229930 A JPH05229930 A JP H05229930A JP 4070197 A JP4070197 A JP 4070197A JP 7019792 A JP7019792 A JP 7019792A JP H05229930 A JPH05229930 A JP H05229930A
Authority
JP
Japan
Prior art keywords
skin
whitening cosmetic
whitening
test
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4070197A
Other languages
Japanese (ja)
Other versions
JP3071293B2 (en
Inventor
Sumie Ishii
純恵 石井
Tatsuro Shinomiya
達郎 四宮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP4070197A priority Critical patent/JP3071293B2/en
Publication of JPH05229930A publication Critical patent/JPH05229930A/en
Application granted granted Critical
Publication of JP3071293B2 publication Critical patent/JP3071293B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To provide a skin-whitening cosmetic which has excellent effect to suppress the red spots caused by ultraviolet rays and the melanin production, further color-lightening the melanin deposit on the skin without irritation to the skin. CONSTITUTION:The objective skin-whitening cosmetic is prepared by compounding the extract from the rhizome of rhatany (Krameria triandra ruiz Pavon).

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮膚安全性に優れ、色
黒の皮膚を速やかに淡色化する効果と紫外線による皮膚
の炎症を予防する効果を有する美白化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic composition having excellent skin safety, having the effect of rapidly lightening dark skin and preventing skin inflammation due to ultraviolet rays.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】紫外線
により皮膚の色調は変化し黒化する。この黒化は、メラ
ノサイトにおいて産生され表皮細胞に受け渡されるメラ
ニンの過剰生産が原因であり、メラニンはチロシンが酸
化されて産生される。
2. Description of the Prior Art Ultraviolet rays change the color tone of skin and turn it black. This blackening is caused by the overproduction of melanin produced in melanocytes and delivered to epidermal cells, and melanin is produced by the oxidation of tyrosine.

【0003】従来より、皮膚の黒化やしみ、そばかすを
防ぎ元の白い肌を保つために、この酸化を防止するビタ
ミンCの塩や脂肪酸誘導体、更にハイドロキノンモノベ
ンジルエーテル、過酸化水素等を配合した美白化粧料が
提案されている。
[0003] Conventionally, in order to prevent skin blackening, stains and freckles and maintain the original white skin, vitamin C salts and fatty acid derivatives which prevent this oxidation, hydroquinone monobenzyl ether, hydrogen peroxide, etc. have been added. Whitening cosmetics have been proposed.

【0004】しかし、これらの美白化粧料中にビタミン
C誘導体を配合すると保存安定性が不充分であるか、紫
外線による炎症抑制効果、美白効果が充分に認められな
いことが多い。一方、美白化粧料中にハイドロキノンモ
ノベンジルエーテル等を配合すると、色黒の肌を淡色化
する効果はあるが、皮膚の安全性上に問題がある等の欠
点がある。この様に、炎症抑制効果、美白効果に優れ且
つ皮膚安全性が高く、保存安定性美白化粧料を得ること
は困難を極めている。
However, when a vitamin C derivative is added to these whitening cosmetics, the storage stability is insufficient, or the anti-inflammatory and whitening effects due to ultraviolet rays are often not sufficiently observed. On the other hand, blending hydroquinone monobenzyl ether or the like into a whitening cosmetic has the effect of lightening dark skin, but has the drawback of causing a problem in terms of skin safety. As described above, it is extremely difficult to obtain a storage-stable whitening cosmetic which has an excellent anti-inflammatory effect and a whitening effect and high skin safety.

【0005】[0005]

【課題を解決するための手段】本発明者らは、このよう
な状況に鑑み、従来技術の難点を改良せんとして鋭意研
究を重ねた結果、ラタニアの根茎から得られる抽出物を
配合したものが、美白効果と炎症抑制効果に優れ、且つ
皮膚安全性が高い、という条件を満足した美白化粧料と
なることを見いだし、本発明の完成に至った。
In view of such a situation, the inventors of the present invention have conducted intensive studies as an improvement of the drawbacks of the prior art, and as a result, have found that the extract obtained from the rhizome of Latania was blended. It was found that the whitening cosmetic composition satisfies the conditions of excellent whitening effect and anti-inflammatory effect and high skin safety, and has completed the present invention.

【0006】即ち、本発明は、炎症抑制効果、美白効果
に優れ、且つ皮膚安全性が高い、美白化粧料を提供する
ことを目的とするものである。
[0006] That is, an object of the present invention is to provide a whitening cosmetic composition which has excellent anti-inflammatory and whitening effects and high skin safety.

【0007】上記の目的を達成するために、本発明の美
白化粧料は、ラタニア(Krameria trian
dra et Pavon)の根茎から得られる抽出物
を配合することを特徴とする美白化粧料である。
In order to achieve the above object, the whitening cosmetic composition of the present invention comprises a latania (Krameria trian).
It is a whitening cosmetic characterized in that it contains an extract obtained from the rhizome of (dra et Pavon).

【0008】本発明の美白化粧料に用いられるラタニア
は、南米原産の灌木で、クラメリア科に属し、学名をK
rameria triandra Pavonとい
う。本抽出物は、その根茎から得られたもので、成分と
しては、タンニン,ラタニン等があり、収斂,抗炎症薬
等、民間薬として用いられていた。
Latania used in the whitening cosmetic composition of the present invention is a shrub native to South America, which belongs to the family Clameria and has a scientific name of K.
It is called rameria triandra Pavon. This extract was obtained from its rhizome and had tannin, rattanin, etc. as its components, and was used as a folk medicine such as astringent, anti-inflammatory drug and the like.

【0009】その抽出物を得るには、乾燥したラタニア
の根茎1000gを細砕して、3000mlのメタノー
ルを加え、水浴中で1時間加熱し、別して粗抽出物17
3.5gを得た。この粗抽出物を酢酸エチル,水を用い
て分画し、得られた水層分画中から粉末状の乾燥物であ
る抽出物27.5gを得た。
To obtain the extract, 1000 g of dried Latania rhizomes were ground, 3000 ml of methanol was added, and the mixture was heated in a water bath for 1 hour.
3.5 g was obtained. The crude extract was fractionated using ethyl acetate and water, and 27.5 g of a powdery dried product was obtained from the resulting aqueous layer fraction.

【0010】ラタニア抽出物の本発明の美白化粧料中へ
の配合量は、総量を基準として、好ましくは、0.01
〜5.0重量%(以下wt%とする)である。
The amount of the Latania extract in the whitening cosmetic composition of the present invention is preferably 0.01 based on the total amount.
˜5.0 wt% (hereinafter referred to as wt%).

【0011】ラタニア抽出物の配合量が0.01w%未
満では本発明の目的とする効果に充分ではなく、ラタニ
ア抽出物の配合量が5.0w%を超えても、その増加分
に見合った効果の向上は望めず、使用時の感触が悪くな
り易く、個々の剤型を保持し難くなる。
If the amount of the Latania extract blended is less than 0.01 w%, the desired effect of the present invention is not sufficient. Even if the amount of the Latania extract blended exceeds 5.0 w%, the increase is commensurate. The improvement of the effect cannot be expected, the feel during use tends to deteriorate, and it becomes difficult to hold the individual dosage forms.

【0012】本発明の美白化粧料は、常法に従って、ロ
ーション類、乳液類、クリーム類、パック類等の剤型に
することが可能である。
The whitening cosmetic composition of the present invention can be formulated into lotions, emulsions, creams, packs and the like according to a conventional method.

【0013】尚、本発明の美白化粧料には、色素、香
料、防腐剤、界面活性剤、顔料等を本発明の目的を達成
する範囲で適宜配合することができる。
In the whitening cosmetic composition of the present invention, a colorant, a fragrance, a preservative, a surfactant, a pigment and the like can be appropriately added within the range where the object of the present invention is achieved.

【0014】[0014]

【実施例】以下、実施例及び比較例に基づいて本発明を
詳細に説明する。
EXAMPLES The present invention will be described in detail below based on examples and comparative examples.

【0015】実施例に記載の(1)チロシナーゼ活性阻
害試験(2)皮膚色明度回復試験(3)美白実用試験
(4)紫外線紅斑抑制試験(5)光パッチ試験の各試験
法は次の通りである。
Each test method of (1) tyrosinase activity inhibition test (2) skin color lightness recovery test (3) whitening practical test (4) ultraviolet erythema suppression test (5) photopatch test described in Examples is as follows. Is.

【0016】(1)チロシナーゼ活性阻害試験 マックルベイン緩衝液(pH6.8)1mlに0.3m
g/ml濃度のチロシン溶液に各濃度の試料溶液を加
え、37℃にて10分間の予備保温を行う。これに1m
g/ml濃度のチロシナーゼ(シグマ社製)0.1ml
を加え37℃にて15分間加温した後、分光光度計を用
いて、波長475nmにて吸光度(A)を測定した。一
方、チロシナーゼの代わりに緩衝液0.1mlを加えた
ものの吸光度(B)、試料溶液の代わりに緩衝液0.1
ml加えたものの吸光度(C)、更に試料溶液とチロシ
ナーゼの代わりに緩衝液0.2ml加えたものの吸光度
(D)をそれぞれ測定して、下式に従い阻害率(%)を
算出した。
(1) Tyrosinase activity inhibition test 0.3 ml per 1 ml of Macklebein buffer (pH 6.8)
A sample solution of each concentration is added to the tyrosine solution of g / ml concentration, and pre-incubation is performed at 37 ° C for 10 minutes. 1m to this
0.1 ml of tyrosinase (manufactured by Sigma) at a concentration of g / ml
Was added and heated at 37 ° C. for 15 minutes, and then the absorbance (A) was measured at a wavelength of 475 nm using a spectrophotometer. On the other hand, the absorbance (B) of 0.1 ml of buffer solution added in place of tyrosinase, 0.1% buffer solution in place of the sample solution.
The absorbance (C) of the solution added with ml and the absorbance (D) of the sample solution added with 0.2 ml of the buffer solution instead of tyrosinase were measured, and the inhibition rate (%) was calculated according to the following formula.

【0017】 阻害率(%)=(A−B)/(C−D)×100Inhibition rate (%) = (A−B) / (C−D) × 100

【0018】(2)皮膚色明度回復試験 被試験者20名の上腕内側部皮膚にUVA、UVB領域
の紫外線の最小紅斑量を3日間連続照射して照射終了
後、試料塗布部とベース塗布部皮膚の基準明度(V0
値、V0 ´値)を測定した。引き続いて、1日3回ずつ
4週間連続で塗布し、照射開始1、2、4週間後の試料
塗布部とベース塗布部皮膚の皮膚明度(Vn値、Vn ´
値)を測定して、下記の判定基準により皮膚色の回復評
価を行った。
(2) Skin color lightness recovery test [0018] The skin of the upper arm of 20 test subjects was irradiated with the minimum amount of erythema of UV rays in the UVA and UVB regions for 3 consecutive days. Standard lightness of skin (V0
Value, V0 'value) was measured. Subsequently, it was applied 3 times a day for 4 consecutive weeks, and the skin lightness (Vn value, Vn ′) of the sample-applied part and the base-applied part skin after 1, 2 and 4 weeks from the start of irradiation
The value) was measured and the skin color recovery was evaluated according to the following criteria.

【0019】尚、皮膚の明度(マンセル表示系V値)
は、高速分光色彩計で測定して得られX、Y、Z値より
算出した。又、評価は被試験者20名の4週間後の評価
点の平均値で示した。
The brightness of the skin (V value of Munsell display system)
Was calculated from the X, Y, and Z values obtained by measurement with a high-speed spectrocolorimeter. The evaluation is shown by the average value of the evaluation points of 20 test subjects after 4 weeks.

【0020】[0020]

【表1】 [Table 1]

【0021】(3)美白実用試験 夏期の太陽光に3時間(1日1.5時間で2日間)曝さ
れた被試験者20名の前腕屈側部皮膚を対象として、左
前腕屈側部皮膚には太陽光に曝された日より、右前腕屈
側部皮膚には太陽光に曝された日の7日後より試料とベ
ースを朝夕1回ずつ13週連続塗布した。尚、評価はベ
ース塗布部より試料塗布部の方が、効果があったと申告
した人数を示した。
(3) Practical Whitening Test A left forearm flexion side part of the forearm flexion side skin of 20 test subjects exposed to summer sunlight for 3 hours (1.5 hours a day for 2 days) From the day of sun exposure to the skin, and to the skin of the right forearm flexor lateral side, the sample and the base were applied once daily in the morning and evening for 13 weeks from 7 days after the day of sun exposure. In the evaluation, the number of people who declared that the sample application section was more effective than the base application section was shown.

【0022】(4)紫外線紅斑抑制試験 除毛したハートレー系モルモット10匹の背部皮膚にU
VB領域の紫外線の最小紅斑量の2倍を各2ヶ所ずつ照
射を行う。24時間前と照射直後に試料を塗布し、試料
塗布部位とベース塗布部位を設定して、24時間後に紅
斑の状態を下記判定基準に従い評価を行った。
(4) UV Erythema Suppression Test U was applied to the dorsal skin of 10 Hartley guinea pigs from which hair had been removed.
Irradiation with two times the minimum erythema dose of ultraviolet rays in the VB region is performed at two locations each. The sample was applied 24 hours before and immediately after irradiation, the sample application site and the base application site were set, and 24 hours later, the erythema state was evaluated according to the following criteria.

【0023】[0023]

【表2】 [Table 2]

【0024】(5)光パッチ試験 被験者25名の前腕屈側部皮膚に試料0.05gを塗布
した直径1.0cmのパッチ板を用いて24時間クロー
ズドパッチを行った後、夏期の太陽光を6時間(1日3
時間で2日間)照射した。
(5) Optical patch test 25 subjects were subjected to closed patch for 24 hours using a patch plate having a diameter of 1.0 cm, which was prepared by applying 0.05 g of the sample to the skin on the flexion side of the forearm, and then exposed to sunlight in summer. 6 hours (3 a day
For 2 days).

【0025】評価は、下記の判定基準に従い、被験者2
5名の皮膚の状態を評価判定した。判定結果は、照射2
4時間後に、(±)以上の人数で示した。
The evaluation was carried out by subject 2 according to the following criteria.
The skin condition of 5 persons was evaluated and judged. Judgment result is irradiation 2
After 4 hours, the number of people was (±) or more.

【0026】[0026]

【表3】 [Table 3]

【0027】実施例1,2、比較例1,2 二相型ロー
ション 表4の原料組成において、表4に記載の如く有効成分を
配合して、二相型ローションを調製し、前記の諸試験を
実施した。
Examples 1 and 2 and Comparative Examples 1 and 2 Two-Phase Lotions In the raw material compositions shown in Table 4, the active ingredients were blended as shown in Table 4 to prepare two-phase lotions, and the above-mentioned various tests were conducted. Was carried out.

【0028】[0028]

【表4】 [Table 4]

【0029】[0029]

【表5】 [Table 5]

【0030】(1)調製法 表4に記載のB成分をC成分中に均一に溶解した後、A
成分とC成分を均一に混合攪拌分散し次いで容器に充填
する。使用時には内容物を均一に振盪分散して使用す
る。
(1) Preparation Method After uniformly dissolving the B component shown in Table 4 in the C component, A
Component C and component C are uniformly mixed, stirred and dispersed, and then filled in a container. At the time of use, the contents should be evenly dispersed by shaking.

【0031】(2)特性 諸試験を実施した結果を表5に記載した。表5に示す如
く、比較例1は諸試験において良好な結果は示さなかっ
た。
(2) Characteristics Table 5 shows the results of various tests. As shown in Table 5, Comparative Example 1 did not show good results in various tests.

【0032】実施例1,2の本発明の美白化粧料は諸試
験の総てにおいて明らかに良好な結果を示し、ヒト皮膚
での諸試験において皮膚刺激は生じなかった。
The whitening cosmetics of the present invention of Examples 1 and 2 showed clearly good results in all the tests, and no skin irritation occurred in the tests on human skin.

【0033】実施例3,4、比較例3,4 スキンクリ
ーム 表6の原料組成において、表7に記載の如く有効成分を
配合して、スキンクリームを調製し、前記の諸試験を実
施した。
Examples 3 and 4, Comparative Examples 3 and 4 Skin Cream The skin cream was prepared by blending the active ingredients in the raw material composition shown in Table 6 as shown in Table 7, and the above-mentioned various tests were carried out.

【0034】[0034]

【表6】 [Table 6]

【0035】[0035]

【表7】 [Table 7]

【0036】(1)調製法 表6に記載のB成分をC成分に混合し、A成分とC成分
をそれぞれ均一に加熱溶解して温度を80℃にする。次
いで、A成分中にC成分を注入攪拌混合した後、攪拌し
ながら冷却し、約50℃にてC成分を投入し30℃まで
冷却する。
(1) Preparation method Component B shown in Table 6 is mixed with component C, and component A and component C are uniformly heated and dissolved to bring the temperature to 80 ° C. Next, the C component is poured into the A component and mixed by stirring, then cooled with stirring, and the C component is charged at about 50 ° C. and cooled to 30 ° C.

【0037】諸試験を実施した結果を表7に示した。表
7に示す如く、実施例3,4は、諸試験の総てにおいて
明らかに良好な結果を示し、ヒト皮膚での諸試験におい
て良好な結果を示し、ヒト皮膚での諸試験において皮膚
刺激は生じなかった。
The results of various tests are shown in Table 7. As shown in Table 7, Examples 3 and 4 clearly show good results in all the tests, good results in the tests on human skin, and no skin irritation in the tests on human skin. Did not happen.

【0038】[0038]

【発明の効果】以上記載の如く、本発明はメラニン色素
の産生抑制効果、皮膚の色素沈着を速やかに淡色化する
効果に及び、紫外線による皮膚の炎症抑制効果に優れ、
皮膚刺激が無い有用な美白化粧料を提供することは明ら
かである。
As described above, the present invention is excellent in the effect of suppressing the production of melanin pigment, the effect of rapidly lightening skin pigmentation, and the effect of suppressing the inflammation of skin by ultraviolet rays.
It is obvious to provide a useful whitening cosmetic which does not cause skin irritation.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ラタニア(Krameria tria
ndra et Pavon)の根茎から得られる抽出
物を配合することを特徴とする美白化粧料。
1. Latania (Krameria tria)
A whitening cosmetic characterized in that it contains an extract obtained from the rhizome of Ndra et Pavon).
JP4070197A 1992-02-19 1992-02-19 Whitening cosmetics Expired - Fee Related JP3071293B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4070197A JP3071293B2 (en) 1992-02-19 1992-02-19 Whitening cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4070197A JP3071293B2 (en) 1992-02-19 1992-02-19 Whitening cosmetics

Publications (2)

Publication Number Publication Date
JPH05229930A true JPH05229930A (en) 1993-09-07
JP3071293B2 JP3071293B2 (en) 2000-07-31

Family

ID=13424553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4070197A Expired - Fee Related JP3071293B2 (en) 1992-02-19 1992-02-19 Whitening cosmetics

Country Status (1)

Country Link
JP (1) JP3071293B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002302416A (en) * 2001-03-30 2002-10-18 Naris Cosmetics Co Ltd Fat synthesis-accelerating agent and cosmetic

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002302416A (en) * 2001-03-30 2002-10-18 Naris Cosmetics Co Ltd Fat synthesis-accelerating agent and cosmetic
JP4611565B2 (en) * 2001-03-30 2011-01-12 株式会社ナリス化粧品 Fat synthesis accelerator and cosmetics

Also Published As

Publication number Publication date
JP3071293B2 (en) 2000-07-31

Similar Documents

Publication Publication Date Title
JP2986262B2 (en) Whitening cosmetics
JP3510751B2 (en) Whitening cosmetics
JP3582936B2 (en) External preparation for skin
JPH05229930A (en) Skin-whitening cosmetic
JP2942409B2 (en) Whitening cosmetics
JP2708692B2 (en) Whitening cosmetics
JP3023249B2 (en) Whitening cosmetics
JP2731329B2 (en) Skin cosmetics
JPH0859452A (en) Skin cosmetic
CN101822624A (en) Composition containing thioctic acid and extract of root of red-rooted salvia and application thereof in cosmetics
JP3045604B2 (en) Whitening cosmetics
KR100415278B1 (en) Skin whitening compositions using the Fragrance
JPH0517202B2 (en)
JP2774035B2 (en) Whitening cosmetics
JP3649889B2 (en) Whitening cosmetics
JPH0363207A (en) Skin cosmetic
JPH0733639A (en) Beautifying and whitening cosmetic
JP3730039B2 (en) Whitening cosmetics
JP2671244B2 (en) Whitening cosmetics
JPH06271454A (en) Skin cosmetic
JPH08337528A (en) Suppressant for melanogenesis
JPH0710738A (en) Beautifying cosmetic
JP3197651B2 (en) Skin cosmetics
JPH06145039A (en) Skin cosmetic
JPH06206812A (en) Skin cosmetic

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080526

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090526

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090526

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100526

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees